The Cleveland Clinic study identified a specific gene, neurobeachin (NBEA), as a predictor of GLP-1 response
It is useful in treating dyskinesias, although it has been shown to be ineffective for the treatment of motor fluctuations
Either way, the decision to take a GLP-1 should always be made individually, with guidance from a qualified healthcare team who understands a person's full health history, goals, and training demands
This condition is not caused by an ongoing infection and does not respond to additional antibiotics
This is the unique third receptor that retatrutide targets, which is not activated by either Wegovy or Mounjaro
Glutathione is absolutely essential for life and required to protect all cells, tissues and organs from oxidative fallout and damage